Xinyuan shares: it is proposed to launch the restricted stock incentive plan in 2022

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

EqualOcean Weekly Hotspots Series (8/17-8/22)

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Meituan's Food Delivery Brand Keeta Launches in Qatar, Plans to Enter Brazil in Months

On August 19 (local time in Qatar), Keeta, the international food delivery brand under Chinese tech and retail giant Meituan, officially launched in Doha, the capital of Qatar. This marks another layout of Keeta in the Middle East market following its entry into Saudi Arabia.

EqualOcean Weekly Hotspots Series (8/10-8/15)

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.